Arpad Szomor
Seregélyesi Road 3
Szekesfehervar, FE 8000, Hungary
Szekesfehervar, FE 8000, Hungary
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Extranodal NK/T-Cell Lymphoma, Nasal Type, Presenting as an Isolated Oral Manifestation.
Journal: Dentistry journal
Published: December 01, 2025
Ixazomib-Lenalidomide-Dexamethasone for the Treatment of Relapsed/Refractory Multiple Myeloma: A Hungarian Real-World Analysis.
Journal: Journal of clinical medicine
Published: December 01, 2025
Camidanlumab tesirine for relapsed or refractory classic Hodgkin lymphoma: a phase 2 study.
Journal: Blood advances
Published: December 10, 2024
Improved survival of autologous stem cell transplantation in primary refractory and relapsed Hodgkin lymphoma in the brentuximab vedotin era - real-world data from Hungary.
Journal: Annals of hematology
Published: March 10, 2023
Absence of Nkx2-3 induces ectopic lymphatic endothelial differentiation associated with impaired extramedullary stress hematopoiesis in the spleen.
Journal: Frontiers in cell and developmental biology
Published: February 20, 2023
Use of blood products during the first months of COVID-19 pandemic period: A single center report.
Journal: Heliyon
Published: June 29, 2022
Two-Year Event-Free Survival Prediction in DLBCL Patients Based on In Vivo Radiomics and Clinical Parameters.
Journal: Frontiers in oncology
Published: November 22, 2021
O-GlcNAcylation in early stages of chronic lymphocytic leukemia: Protocol development for flow cytometry.
Journal: Cancer biomarkers : section A of Disease markers
Published: June 21, 2021
Effect of SARS-CoV-2 pandemic on blood product usage at the University of Pécs
Journal: Orvosi hetilap
Published: June 14, 2021
Copanlisib plus rituximab versus placebo plus rituximab in patients with relapsed indolent non-Hodgkin lymphoma (CHRONOS-3): a double-blind, randomised, placebo-controlled, phase 3 trial.
Journal: The Lancet. Oncology
Published: January 08, 2021
Real-world efficacy of brentuximab vedotin plus bendamustine as a bridge to autologous hematopoietic stem cell transplantation in primary refractory or relapsed classical Hodgkin lymphoma.
Journal: Annals of hematology
Published: January 27, 2020
Correlations between secondary hypogammaglobulinaemia, infections and mortality and the need for preventive immunoglobulin replacement in patients with chronic lymphoid leukaemia
Journal: Orvosi hetilap
Published: September 21, 2019
Last Updated: 09/26/2026